Literature DB >> 24452632

User-identified gel characteristics: a qualitative exploration of perceived product efficacy of topical vaginal microbicides.

Kathleen M Morrow1, Kristen Underhill, Jacob J van den Berg, Sara Vargas, Rochelle K Rosen, David F Katz.   

Abstract

Research has demonstrated that certain vaginal gel products--microbicides containing antiretroviral drugs--may reduce HIV infection risk among women. But for vaginal gels to avert HIV and other sexually transmitted infections (STIs), at-risk women must be willing to use them as directed. These products must therefore be "acceptable" to women and an important component of acceptability is users' perception that the product will work to prevent infection. We sought to understand how women's perceptions of vaginal gel properties may shape their understanding of product efficacy for HIV and STI prevention. Sixteen women completed two in-depth qualitative interviews (k = 32) to identify the range and types of sensory perceptions they experienced when using two vaginal gels. We identified emergent themes and linkages between users' sensory perceptions and their beliefs about product efficacy. Users' predictions about product efficacy for preventing infection corresponded to measurable physical properties, including gel volume, location in the vagina, coating behavior, sensation of the gel in the vagina, leakage, and gel changes during coital acts. Although the women described similar sensory experiences (e.g., gel leaked from the vagina), they interpreted these experiences to have varying implications for product efficacy (e.g., leakage was predicted to increase or decrease efficacy). To improve microbicide acceptability, gel developers should investigate and deliberately incorporate properties that influence users' perceptions of efficacy. When a microbicide is approved for use, providers should educate users to anticipate and understand their sensory experiences; improving users' experience can maximize adherence and product effectiveness.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24452632      PMCID: PMC4327860          DOI: 10.1007/s10508-013-0235-5

Source DB:  PubMed          Journal:  Arch Sex Behav        ISSN: 0004-0002


  22 in total

1.  Topical microbicide use by adolescent girls: concerns about timing, efficacy, and safety.

Authors:  Mary B Short; Lisa Mills; Jasmine M Majkowski; Lawrence R Stanberry; Susan L Rosenthal
Journal:  Sex Transm Dis       Date:  2003-11       Impact factor: 2.830

2.  Willingness to use microbicides is affected by the importance of product characteristics, use parameters, and protective properties.

Authors:  Kathleen M Morrow; Joseph L Fava; Rochelle K Rosen; Sara Vargas; Candelaria Barroso; Anna L Christensen; Cynthia Woodsong; Lawrence Severy
Journal:  J Acquir Immune Defic Syndr       Date:  2007-05-01       Impact factor: 3.731

3.  Assessing microbicide acceptability: a comprehensive and integrated approach.

Authors:  Kathleen M Morrow; Monica S Ruiz
Journal:  AIDS Behav       Date:  2007-06-26

4.  Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties.

Authors:  Kathleen M Morrow; Joseph L Fava; Rochelle K Rosen; Sara Vargas; Julia G Shaw; E Milu Kojic; Patrick F Kiser; David R Friend; David F Katz
Journal:  AIDS Res Hum Retroviruses       Date:  2013-12-09       Impact factor: 2.205

5.  The promises and limitations of female-initiated methods of HIV/STI protection.

Authors:  Joanne E Mantell; Shari L Dworkin; Theresa M Exner; Susie Hoffman; Jenni A Smit; Ida Susser
Journal:  Soc Sci Med       Date:  2006-07-11       Impact factor: 4.634

Review 6.  Microbicide acceptability research: current approaches and future directions.

Authors:  Joanne E Mantell; Landon Myer; Alex Carballo-Diéguez; Zena Stein; Gita Ramjee; Neetha S Morar; Polly F Harrison
Journal:  Soc Sci Med       Date:  2005-01       Impact factor: 4.634

7.  "We have our protector": misperceptions of protection against HIV among participants in a microbicide efficacy trial.

Authors:  Joanne E Mantell; Neetha S Morar; Landon Myer; Gita Ramjee
Journal:  Am J Public Health       Date:  2006-05-02       Impact factor: 9.308

8.  Predictors of using a microbicide-like product among adolescent girls.

Authors:  Mary B Short; Paul A Succop; Ana M Ugueto; Susan L Rosenthal
Journal:  J Adolesc Health       Date:  2007-07-20       Impact factor: 5.012

9.  Willingness to use microbicides varies by race/ethnicity, experience with prevention products, and partner type.

Authors:  Kathleen M Morrow; Joseph L Fava; Rochelle K Rosen; Anna L Christensen; Sara Vargas; Candelaria Barroso
Journal:  Health Psychol       Date:  2007-11       Impact factor: 4.267

10.  The importance of context: model projections on how microbicide impact could be affected by the underlying epidemiologic and behavioral situation in 2 African settings.

Authors:  Peter Vickerman; Charlotte Watts; Sinead Delany; Michel Alary; Helen Rees; Lori Heise
Journal:  Sex Transm Dis       Date:  2006-06       Impact factor: 2.830

View more
  22 in total

1.  Achieving the optimal vaginal state: using vaginal products and study gels in Uganda, Zimbabwe, and South Africa.

Authors:  Zoe Duby; Barbara Mensch; Miriam Hartmann; Elizabeth Montgomery; Imelda Mahaka; Linda-Gail Bekker; Ariane van der Straten
Journal:  Int J Sex Health       Date:  2017-03-27

2.  Meaning-making matters in product design: users' sensory perceptions and experience evaluations of long-acting vaginal gels and intravaginal rings.

Authors:  Rochelle K Rosen; Jacob J van den Berg; Sara E Vargas; Natali Senocak; Julia G Shaw; Robert W Buckheit; Kelley Alison Smith; Kate Morrow Guthrie
Journal:  Contraception       Date:  2015-08-11       Impact factor: 3.375

3.  Innovative sensory methods to access acceptability of mixed polymer semisoft ovules for microbicide applications.

Authors:  Toral Zaveri; Cordelia A Running; Lahari Surapaneni; Gregory R Ziegler; John E Hayes
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

4.  A Qualitative Systematic Review of Women's Experiences Using Contraceptive Vaginal Rings: Implications for New Technologies.

Authors:  Sara E Vargas; Miriam M Midoun; Melissa Guillen; Melissa L Getz; Kristen Underhill; Caroline Kuo; Kate M Guthrie
Journal:  Perspect Sex Reprod Health       Date:  2019-05-20

5.  The Role of Volume in the Perceptibility of Topical Vaginal Formulations: User Sensory Perceptions and Experiences of Heterosexual Couples During Vaginal Sex.

Authors:  Kate M Guthrie; Joseph L Fava; Sara E Vargas; Rochelle K Rosen; Julia G Shaw; Erna M Kojic; Anthony S Ham; Lisa C Rohan; David Katz; Anacecilia Panameño; Christopher Colleran; David F Friend; Karen W Buckheit; Robert W Buckheit
Journal:  AIDS Res Hum Retroviruses       Date:  2020-11-03       Impact factor: 2.205

6.  Factors Supporting and Hindering Adherence to Rectal Microbicide Gel Use with Receptive Anal Intercourse in a Phase 2 Trial.

Authors:  Rebecca Giguere; Christine Tagliaferri Rael; Alan Sheinfil; Ivan C Balán; William Brown; Titcha Ho; Curtis Dolezal; Cheng-Shiun Leu; Albert Liu; Kenneth H Mayer; Javier R Lama; Ian McGowan; Alex Carballo-Diéguez; Ross D Cranston
Journal:  AIDS Behav       Date:  2018-02

Review 7.  Designing and developing suppository formulations for anti-HIV drug delivery.

Authors:  Anthony S Ham; Robert W Buckheit
Journal:  Ther Deliv       Date:  2017-08

8.  User input in iterative design for prevention product development: leveraging interdisciplinary methods to optimize effectiveness.

Authors:  Kate M Guthrie; Rochelle K Rosen; Sara E Vargas; Melissa Guillen; Arielle L Steger; Melissa L Getz; Kelley A Smith; Jaime J Ramirez; Erna M Kojic
Journal:  Drug Deliv Transl Res       Date:  2017-10       Impact factor: 4.617

Review 9.  On-demand microbicide products: design matters.

Authors:  Sravan Kumar Patel; Lisa Cencia Rohan
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 4.617

Review 10.  Clinical evaluation of microbicide formulations.

Authors:  Kathleen M Morrow; Craig Hendrix
Journal:  Antiviral Res       Date:  2010-12       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.